EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitamin D: A Nutraceutical Supplement at the Crossroad Between Respiratory Infections and COVID-19

Manuela Rizzi iD, Pier Paolo Sainaghi iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062550 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Manuela Rizzi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences (DiSS), Università del Piemonte Orientale (UPO), 28100 Novara, Italy. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, COVID-19, COVID-19 Drug Treatment. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Even though in mid-2023 the World Health Organization declared the end of the public health emergency of international concern status for COVID-19, many areas of uncertainty about SARS-CoV-2 infection pathophysiology remain. Although in the last 4 years pharmaceutical industries widely invested in the development of effective antiviral treatments and vaccines, large disparities in their availability worldwide still exist, thus fostering the investigation of nutritional supplements as adjuvant therapeutic approaches for disease management, especially in resource-limited settings. During the COVID-19 pandemic, vitamin D has been widely used as an over-the-counter solution to improve disease evolution, thanks to its known immunomodulatory and anti-inflammatory actions. Ecological and observational studies support a relationship between hypovitaminosis D and COVID-19 negative outcomes and, according to this evidence, several research groups investigated the role of vitamin D supplementation in protecting from SARS-CoV-2 infection and/or improving disease evolution. This narrative review is intended to offer insights into the existing data on vitamin D’s biological effects in respiratory infections, especially in COVID-19. Furthermore, it will also offer a brief overview of the complex interplay between vitamin D and vaccine-elicited immune response, with special attention to anti-COVID-19 vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DDietary SupplementsCOVID-19COVID-19 Drug TreatmentRespiratory Tract InfectionsHumansSARS-CoV-2Vitamin D Deficiency

Stichwörter der Autor:innen

COVID-19SARS-CoV-2clinical trialsimmunomodulationrespiratory infectionsvitamin D

Substanzen

Vitamin D

Autor:innen und Institutionen

  • Department of Health Sciences (DiSS), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.
  • IRCAD (Interdisciplinary Research Center of Autoimmune Diseases), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.
  • Department of Translational Medicine (DiMeT), Università del Piemonte Orientale (UPO), 28100 Novara, Italy.

ORCID-Profile: Manuela Rizzi, Pier Paolo Sainaghi

Zitieren

APA

Rizzi, M., & Sainaghi, P. P. (2025). Vitamin D: A Nutraceutical Supplement at the Crossroad Between Respiratory Infections and COVID-19. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062550

Vancouver

Rizzi M, Sainaghi PP. Vitamin D: A Nutraceutical Supplement at the Crossroad Between Respiratory Infections and COVID-19. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062550

BibTeX
@article{Rizzi2025,
  author = {Rizzi, Manuela and Sainaghi, Pier Paolo},
  title = {Vitamin D: A Nutraceutical Supplement at the Crossroad Between Respiratory Infections and COVID-19},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062550}
}
Kostenlos starten →